Product Images Kali Arsenicosum

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Kali Arsenicosum NDC 0220-2847 by Boiron, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

label - 2ND PANEL

label - 2ND PANEL

This appears to be information related to drug facts, with a mention of inactive ingredients. The text also includes contact information for Boiron USA, along with their website. There is a reference to homeopathic dilutions and a suggestion to visit their website for further details. The last line is not clear and appears to contain non-English characters.*

label - 3RD PANEL

label - 3RD PANEL

This is a description of a drug containing an active ingredient with a specific quantity per pellet. The uses of the drug are listed on the front panel, and the warnings include seeking medical attention if symptoms worsen or persist for more than three days, caution for pregnant or breastfeeding women to consult a health professional before use, and keeping it out of reach of children. The recommended dosage for adults and children is provided in the directions, and it is advised not to use a pellet dispenser if the seal is broken.*

label - KALARS200CK

label - KALARS200CK

Kali arsenicosum 200 is a homeopathic medicine that can be used for dry skin rash with itching that worsens with heat. The medicine comes in pellets, with approximately 80 in each container. The Lot Exp and instructions for use are provided on the package. The HPUS NDC code for this medicine is 0220-2847-41.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.